SCHEMBL10153664

SCHEMBL10153664

O=C(C1C(=O)N(O)C(=O)c2ccccc21)N1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.46
ALDH1A1 P00352 6/20 0.46
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.43
XBP1 P17861 1/20 0.43
HIF1A Q16665 1/20 0.43
HPGD P15428 3/20 0.42
GAA P10253 3/20 0.42
KMT2A Q03164 2/20 0.42
HSD17B10 Q99714 1/20 0.42
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40
ACHE P22303 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
GLA P06280 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11789328 0.83 TSHR (0.48) TSHRALDH1A1HTTHPGDGAA
SCHEMBL11789850 0.77 ALDH1A1 (0.43) ALDH1A1HTTLMNAHPGDGAA
SCHEMBL10153632 0.77 PREP (0.45) TSHRALDH1A1HPGDKMT2AKDM4E
SCHEMBL9952800 0.76 ATM (0.42) ALDH1A1LMNAHPGDGAAKMT2A
SCHEMBL31653964 0.75 TSHR (0.59) TSHRALDH1A1HTTLMNAGAA
SCHEMBL9958705 0.74 HDAC4 (0.62) TSHRALDH1A1HTTLMNAHPGD
SCHEMBL10153699 0.73 TSHR (0.57) TSHRALDH1A1HTTLMNAGAA
SCHEMBL19380301 0.72 HDAC3 (0.40) TSHRALDH1A1GAAKMT2AHSD17B10
SCHEMBL19380274 0.72 HDAC4 (0.44) TSHRALDH1A1HTTLMNAGAA
SCHEMBL10154010 0.72 MAPT (0.44) TSHRHTTKMT2AHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085003-A1 2-HYDROXYISOQUINOLINE-1,3(2H,4H)-DIONES AND RELATED COMPOUNDS USEFUL AS HIV REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-06-28 WO disclosed